GLAUKOS Corp Operating Lease, Right-of-Use Asset, Amortization Expense
GLAUKOS Corp (GKOS) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $2.36 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-07-29
- GLAUKOS Corp operating lease, right-of-use asset, amortization expense for the quarter ending 2026-06-30 was $1.27M, a 20.57% increase year-over-year.
- GLAUKOS Corp operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $1.08M, a 0.65% increase year-over-year.
- GLAUKOS Corp operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $1.06M, a 1.30% decline year-over-year.
- GLAUKOS Corp operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $1.05M, a 0.66% decline year-over-year.
- GLAUKOS Corp operating lease, right-of-use asset, amortization expense for fiscal 2025 was $4.25M, a 0.47% decline from fiscal 2024.
- GLAUKOS Corp operating lease, right-of-use asset, amortization expense for fiscal 2024 was $4.27M, a 1.20% decline from fiscal 2023.
- GLAUKOS Corp operating lease, right-of-use asset, amortization expense for fiscal 2023 was $4.32M, a 1.05% decline from fiscal 2022.
- GLAUKOS Corp operating lease, right-of-use asset, amortization expense for fiscal 2022 was $4.37M, a 8.19% decline from fiscal 2021.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $2.36M 10-Q · filed 2026-07-29 | $3.42M derived: sum of 3 quarters · filed 2026-07-29 | $4.48M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | $1.08M 10-Q · filed 2026-04-30 | $2.15M derived: sum of 2 quarters · filed 2026-04-30 | $3.20M derived: sum of 3 quarters · filed 2026-04-30 | $4.26M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $2.12M derived: sum of 2 quarters · filed 2026-02-23 | $3.17M derived: sum of 3 quarters · filed 2026-07-29 | $4.25M 10-K · filed 2026-02-23 |
| 2025-09-30 | $1.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-31 | $2.11M derived: sum of 2 quarters · filed 2026-07-29 | $3.19M 10-Q · filed 2025-10-31 | $4.27M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $1.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $2.13M 10-Q · filed 2026-07-29 | $3.21M derived: sum of 3 quarters · filed 2026-07-29 | $4.27M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $1.08M 10-Q · filed 2026-04-30 | $2.16M derived: sum of 2 quarters · filed 2026-04-30 | $3.22M derived: sum of 3 quarters · filed 2026-04-30 | $4.28M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $2.14M derived: sum of 2 quarters · filed 2026-02-23 | $3.20M derived: sum of 3 quarters · filed 2026-02-23 | $4.27M 10-K · filed 2026-02-23 |
| 2024-09-30 | $1.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-31 | $2.12M derived: sum of 2 quarters · filed 2025-10-31 | $3.19M 10-Q · filed 2025-10-31 | $4.30M derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-06-30 | $1.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $2.13M 10-Q · filed 2025-08-04 | $3.24M derived: sum of 3 quarters · filed 2026-02-23 | $4.28M derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-03-31 | $1.07M 10-Q · filed 2025-05-01 | $2.18M derived: sum of 2 quarters · filed 2026-02-23 | $3.21M derived: sum of 3 quarters · filed 2026-02-23 | $4.36M derived: sum of 4 quarters · filed 2026-02-23 |
| 2023-12-31 | $1.11M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $2.14M derived: sum of 2 quarters · filed 2026-02-23 | $3.29M derived: sum of 3 quarters · filed 2026-02-23 | $4.32M 10-K · filed 2026-02-23 |
| 2023-09-30 | $1.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $2.18M derived: sum of 2 quarters · filed 2024-11-05 | $3.22M 10-Q · filed 2024-11-05 | $4.21M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $1.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $2.18M 10-Q · filed 2024-08-02 | $3.17M derived: sum of 3 quarters · filed 2025-02-25 | $4.25M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $1.04M 10-Q · filed 2024-05-03 | $2.03M derived: sum of 2 quarters · filed 2025-02-25 | $3.11M derived: sum of 3 quarters · filed 2025-02-25 | $4.13M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $992.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $2.07M derived: sum of 2 quarters · filed 2025-02-25 | $3.10M derived: sum of 3 quarters · filed 2025-02-25 | $4.37M 10-K · filed 2025-02-25 |
| 2022-09-30 | $1.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $2.11M derived: sum of 2 quarters · filed 2023-11-01 | $3.38M 10-Q · filed 2023-11-01 | $4.62M derived: sum of 4 quarters · filed 2024-02-23 |
| 2022-06-30 | $1.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $2.30M 10-Q · filed 2023-08-02 | $3.54M derived: sum of 3 quarters · filed 2024-02-23 | $4.77M derived: sum of 4 quarters · filed 2024-02-23 |
| 2022-03-31 | $1.27M 10-Q · filed 2023-05-04 | $2.51M derived: sum of 2 quarters · filed 2024-02-23 | $3.74M derived: sum of 3 quarters · filed 2024-02-23 | $4.86M derived: sum of 4 quarters · filed 2024-02-23 |
| 2021-12-31 | $1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $2.47M derived: sum of 2 quarters · filed 2024-02-23 | $3.59M derived: sum of 3 quarters · filed 2024-02-23 | $4.76M 10-K · filed 2024-02-23 |
| 2021-09-30 | $1.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $2.35M derived: sum of 2 quarters · filed 2022-11-04 | $3.52M 10-Q · filed 2022-11-04 | |
| 2021-06-30 | $1.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $2.29M 10-Q · filed 2022-08-05 | ||
| 2021-03-31 | $1.17M 10-Q · filed 2022-05-05 | |||
| 2020-12-31 | $5.23M 10-K · filed 2023-02-24 | |||
| 2019-12-31 | $3.56M 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |